MICROBIOME THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Microbiome Therapeutics Market, By Product Type (Rebyota, Vowst, Biomictra, and Late Phase Products), By Route of Administration (Oral and Rectal), By Care Setting (Hospitals, Specialty Pharmacies, and Physicians Clinics), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 17 Apr, 2026
Code: CMI9441
Page number: 168
Formats: Excel and PDF
Industry: Biotechnology
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

The global microbiome therapeutics market is estimated to be valued at USD 57.4 Mn in 2026 and is expected to reach USD 310.6 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 27.3% from 2026 to 2033. The global microbiome therapeutics market is an innovative field in the healthcare sector that utilizes the biological interaction between the microorganisms in the body to offer protection from various diseases and treatment. This is achieved through rebalancing of the microbiome community by use of different forms of therapeutics, including live biotherapeutics products, drugs made from the microbiome, and engineered microbial communities. The evidence that has been emerging showing the link between dysbiosis in the microbiome community and disease development has contributed to increased interests in this area.

The advancements in next-generation sequencing, computational, and synthetic biology technology have made it possible to produce custom-made microbiome therapies that align well with the current trend in precision medicine. This has made some of the big pharma companies invest heavily in the microbiome industry due to its potential in solving health issues that can only be addressed by conventional methods.

Market Dynamics

The global microbiome therapeutics market has gained traction due to the rise in prevalence of chronic ailments including inflammatory bowel diseases, Crohn’s disease, and ulcerative colitis. Since these ailments are highly dependent on microbiome imbalance, they require innovative therapies for treatment. Rising awareness among the medical practitioners and patients about the role played by gut microbiomes in their general well-being has further spurred demand for new microbiome-based products. Scientific breakthroughs in genomics, bioinformatics, and synthetic biology have made it easier to develop therapeutics successfully. Nevertheless, various challenges remain as regulatory norms and lengthy clinical validation processes make it tough to develop products along with high costs associated with the process of creation and diverse nature of microbiome.

Nevertheless, there are multiple chances offered by the market with the development of applications of microbiomes from gastrointestinal problems to oncological, metabolic, neurology, and dermatology issues. The introduction of personalized therapy according to an individual microbiome profile contributes to changes in treatment techniques and corresponds to the current tendencies of precision medicine. In addition, more and more joint efforts of biotech companies and academic institutions are leading to increased innovations and research commercialization.

Key Features of the Study

This report provides in-depth analysis of the global microbiome therapeutics market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global microbiome therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Seres Therapeutics, Inc., Vedanta Biosciences, Inc., Finch Therapeutics Group, Inc., Enterome SA, 4D Pharma plc, Locus Biosciences, Inc., Rebiotix Inc., Second Genome Therapeutics, Microbiotica Ltd., and Synlogic, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global microbiome therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microbiome therapeutics market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Rebyota
- Vowst
- Biomictra
- Late Phase Products
Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Oral
- Rectal
Care Setting Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Specialty Pharmacies
- Physicians Clinics
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Seres Therapeutics, Inc.
- Vedanta Biosciences, Inc.
- Finch Therapeutics Group, Inc.
- Enterome SA
- 4D Pharma plc
- Locus Biosciences, Inc.
- Rebiotix Inc.
- Second Genome Therapeutics
- Microbiotica Ltd.
- Synlogic, Inc.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Microbiome Therapeutics Market, By Product Type
  - Global Microbiome Therapeutics Market, By Route of Administration
  - Global Microbiome Therapeutics Market, By Care Setting
  - Global Microbiome Therapeutics Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
Global Microbiome Therapeutics Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Rebyota
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vowst
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Biomictra
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Late Phase Products
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Microbiome Therapeutics Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Rectal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Microbiome Therapeutics Market, By Care Setting, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Specialty Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Physicians Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Microbiome Therapeutics Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Care Setting, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Care Setting, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Care Setting, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Care Setting, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Care Setting, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Care Setting, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Seres Therapeutics, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Vedanta Biosciences, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Finch Therapeutics Group, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Enterome SA
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- 4D Pharma plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Locus Biosciences, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Rebiotix Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Second Genome Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Microbiotica Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Synlogic, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Microbiome Therapeutics Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now